Home » Topics » BioWorld Science

BioWorld Science
RSS

NCI sponsors clinical trials with Therion's prostate cancer vaccine

Nov. 22, 1996

Guilford's orally active neuroimmunophilin highly effective in animal models of Parkinson's disease

Nov. 22, 1996

RESTORE trial results presented at AHA meeting

Nov. 22, 1996

ACE inhibitor-AT antagonist combination therapy results presented at AHA congress

Nov. 22, 1996

Interim clinical results with Ansan's cancer product

Nov. 22, 1996

Calcium channel blocker update

Nov. 22, 1996

Quidel and Bayer collaborate on diagnostic tests

Nov. 22, 1996

LeukoSite and Warner-Lambert collaborate on drugs blocking the CCR5 receptor

Nov. 22, 1996

New target for drug-resistant tumors identified

Nov. 22, 1996

Candela laser systems approved in Japan

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...